NPs Basic Information
|
Name |
5-methyl alternariol ether
|
| Molecular Formula | C15H12O5 | |
| IUPAC Name* |
3,7-dihydroxy-9-methoxy-1-methylbenzo[c]chromen-6-one
|
|
| SMILES |
COc1cc(O)c2c(=O)oc3cc(O)cc(C)c3c2c1
|
|
| InChI |
InChI=1S/C15H12O5/c1-7-3-8(16)4-12-13(7)10-5-9(19-2)6-11(17)14(10)15(18)20-12/h3-6,16-17H,1-2H3
|
|
| InChIKey |
LCSDQFNUYFTXMT-UHFFFAOYSA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | NA | |
| ChEMBL ID | NA |
*Note: the IUPAC Name was calculated by STOUT. Reference: PMID:33906675.
Chemical Classification: |
|
|
|---|
——————————————————————————————————————————
NPs Species Source
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
NPs Biological Activity
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
NPs Physi-Chem Properties
| Molecular Weight: | 272.26 | ALogp: | 2.7 |
| HBD: | 2 | HBA: | 5 |
| Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 79.9 | Aromatic Rings: | 3 |
| Heavy Atoms: | 20 | QED Weighted: | 0.523 |
——————————————————————————————————————————
NPs ADMET Properties*
ADMET: Absorption
| Caco-2 Permeability: | -4.951 | MDCK Permeability: | 0.00000918 |
| Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.99 |
| Human Intestinal Absorption (HIA): | 0.022 | 20% Bioavailability (F20%): | 0.023 |
| 30% Bioavailability (F30%): | 0.993 |
——————————————————————————————————————————
ADMET: Distribution
| Blood-Brain-Barrier Penetration (BBB): | 0.016 | Plasma Protein Binding (PPB): | 93.72% |
| Volume Distribution (VD): | 0.721 | Fu: | 9.28% |
——————————————————————————————————————————
ADMET: Metabolism
| CYP1A2-inhibitor: | 0.986 | CYP1A2-substrate: | 0.921 |
| CYP2C19-inhibitor: | 0.496 | CYP2C19-substrate: | 0.081 |
| CYP2C9-inhibitor: | 0.618 | CYP2C9-substrate: | 0.953 |
| CYP2D6-inhibitor: | 0.766 | CYP2D6-substrate: | 0.887 |
| CYP3A4-inhibitor: | 0.498 | CYP3A4-substrate: | 0.104 |
——————————————————————————————————————————
ADMET: Excretion
| Clearance (CL): | 6.851 | Half-life (T1/2): | 0.629 |
——————————————————————————————————————————
ADMET: Toxicity
| hERG Blockers: | 0.017 | Human Hepatotoxicity (H-HT): | 0.191 |
| Drug-inuced Liver Injury (DILI): | 0.954 | AMES Toxicity: | 0.376 |
| Rat Oral Acute Toxicity: | 0.052 | Maximum Recommended Daily Dose: | 0.913 |
| Skin Sensitization: | 0.87 | Carcinogencity: | 0.029 |
| Eye Corrosion: | 0.387 | Eye Irritation: | 0.978 |
| Respiratory Toxicity: | 0.362 |
——————————————————————————————————————————
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.
Similar Compounds*
Compounds similar to EMNPD with top10 similarity:
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001653 |  |
1.000 | D04AIT |  |
0.413 | ||
| ENC004846 |  |
1.000 | D0K8KX |  |
0.386 | ||
| ENC005191 |  |
1.000 | D06GCK |  |
0.363 | ||
| ENC003430 |  |
0.766 | D07MGA |  |
0.333 | ||
| ENC004845 |  |
0.766 | D0FA2O |  |
0.291 | ||
| ENC001652 |  |
0.754 | D0G4KG |  |
0.286 | ||
| ENC001750 |  |
0.746 | D04UTT |  |
0.267 | ||
| ENC002692 |  |
0.697 | D0AZ8C |  |
0.254 | ||
| ENC002516 |  |
0.672 | D0G5UB |  |
0.250 | ||
| ENC002134 |  |
0.643 | D02TJS |  |
0.248 | ||